Compare CADL & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | LE |
|---|---|---|
| Founded | 1999 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 334.7M |
| IPO Year | 2021 | 1994 |
| Metric | CADL | LE |
|---|---|---|
| Price | $6.20 | $11.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $19.00 | ★ $32.50 |
| AVG Volume (30 Days) | ★ 1.7M | 366.8K |
| Earning Date | 05-14-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ 0.18 |
| Revenue | $125,000.00 | ★ $1,162,769,000.00 |
| Revenue This Year | N/A | $5.53 |
| Revenue Next Year | N/A | $2.48 |
| P/E Ratio | ★ N/A | $63.50 |
| Revenue Growth | N/A | ★ 0.72 |
| 52 Week Low | $4.34 | $7.65 |
| 52 Week High | $7.66 | $20.04 |
| Indicator | CADL | LE |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 38.50 |
| Support Level | $5.42 | $10.01 |
| Resistance Level | $6.41 | $16.50 |
| Average True Range (ATR) | 0.48 | 0.57 |
| MACD | 0.09 | 0.11 |
| Stochastic Oscillator | 49.22 | 17.03 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Lands' End Inc is a United States-based digital retailer of solution-based apparel, swimwear, outerwear, accessories, footwear, home products, and uniforms. It offers products online at the website (www.landsend.com), through third-party distribution channels, its own company-operated stores, and third-party license agreements. Lands' End also offers products to businesses and schools, for their employees and students, through the Outfitters distribution channel. The company's operating segments consist of: U.S. eCommerce, Europe eCommerce, Outfitters, Third Party, Licensing, and Retail. The majority of its revenue is generated from the U.S. eCommerce segment. Geographically, Lands' End derives maximum revenue from the United States, and the rest from Europe and other markets.